Premium
Cancer Therapy: Low‐Dose Prostate Cancer Brachytherapy with Radioactive Palladium–Gold Nanoparticles (Adv. Healthcare Mater. 4/2017)
Author(s) -
LaprisePelletier Myriam,
Lagueux Jean,
Côté MarieFrance,
LaGrange Thomas,
Fortin MarcAndré
Publication year - 2017
Publication title -
advanced healthcare materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.288
H-Index - 90
eISSN - 2192-2659
pISSN - 2192-2640
DOI - 10.1002/adhm.201770018
Subject(s) - brachytherapy , prostate cancer , cancer , medicine , radiation therapy , colloidal gold , nuclear medicine , materials science , prostate , oncology , biomedical engineering , nanoparticle , radiology , nanotechnology
Prostate cancer is often treated by internal radiotherapy (brachytherapy), by which tens of radioactive implants made of massive metal « seeds » are inserted in the diseased tissue. Article number 1601120 by Marc‐André Fortin and co‐workers, reports on a new technology based on the injection of radioactive gold nanoparticles. The nanoparticles diffuse into the tumour, where they progressively deliver a radiotherapeutic dose more precisely and with fewer potential side‐effects.